Does bupropion cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Bupropion Cause Constipation?

Yes, constipation is a well-established and common side effect of bupropion across all formulations. This adverse effect is consistently documented in FDA labeling, clinical guidelines, and research literature.

Evidence from FDA Labeling and Guidelines

Constipation is explicitly listed as one of the most common side effects of bupropion in the FDA-approved drug label 1. The American Diabetes Association guidelines identify constipation as a common side effect when bupropion is used in combination with naltrexone for weight management 2. The American College of Cardiology and other medical societies acknowledge that bupropion commonly causes constipation along with dry mouth, insomnia, headache, dizziness, nausea, and tremor 3.

Frequency and Clinical Significance

  • Constipation occurs frequently enough to be listed among the primary common adverse effects across multiple authoritative sources 2, 3, 1
  • In clinical trials of naltrexone/bupropion combinations for obesity, approximately half of patients experienced gastrointestinal disorders including constipation 4
  • The constipation can range from mild to severe, with at least one documented case requiring surgical intervention 5

Clinical Case Evidence

A published case report documented severe constipation leading to thrombotic hemorrhoids requiring hemorrhoidectomy in a 38-year-old man taking extended-release bupropion 150 mg daily 5. The constipation developed within three weeks of starting treatment and resolved only after discontinuation of bupropion, establishing a clear temporal relationship 5.

Mechanism and Formulation Considerations

  • All bupropion formulations (immediate-release, sustained-release, and extended-release) are associated with constipation 6, 7
  • The mechanism likely relates to bupropion's effects on norepinephrine and dopamine neurotransmission, which can affect gastrointestinal motility 6
  • Constipation is reported as a common adverse effect in both depression treatment and smoking cessation indications 7

Clinical Management Recommendations

When prescribing bupropion, clinicians should:

  • Proactively counsel patients about the risk of constipation before initiating therapy 3, 1
  • Recommend preventive measures including increased fluid intake, dietary fiber, and regular exercise 5
  • Consider prophylactic stool softeners (such as docusate sodium) for patients at higher risk 5
  • Monitor for constipation at follow-up visits, particularly in the first few weeks of treatment 5
  • Be prepared to discontinue bupropion if severe constipation develops that does not respond to conservative management 5

Important Caveats

While constipation is common, it should not be confused with contraindications related to eating disorders 3. Bupropion is contraindicated in patients with anorexia or bulimia nervosa due to increased seizure risk, not because of gastrointestinal effects 3. Simple nausea or vomiting are side effects, not contraindications 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bupropion Side Effects and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Severe constipation associated with extended-release bupropion therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Research

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

Primary care companion to the Journal of clinical psychiatry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.